The global demand for Lung Cancer Surgery Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Lung cancer surgery refers to a procedure that removes lung tumor, lymph nodes present in the tumour area and a portion of healthy tissues in the surroundings. It involves resection of non-small cell lung cancer in its early stage. It is considered as the best treatment option for localized lung cancer that has not yet spread. However, the type, stage, size, and location of the cancer are considered along with the patient’s general health condition before carrying out the surgery. Most lung cancer surgeries are performed by following the minimally invasive technique. Some common lung cancer surgeries include wedge resection, lobectomy, sleeve resection and pneumonectomy. The different approaches to lung surgery are open surgery (thoracotomy), video-assisted thoracic surgery and robotic-assisted surgery.
The global lung cancer surgery market is anticipated to witness significant growth during the forecast period. The key factor driving the target market is the increasing incidence of lung cancer across the globe. Increasing addiction to tobacco and a rise in the geriatric population are other chief growth factors for the lung cancer surgery market. Growing awareness related to early diagnosis of cancers and treatment of the same will augment market growth. The market will be favoured by technological advancements made in this field. Furthermore, growing air pollution concerns in emerging economies are likely to positively impact the market. On the other hand, postoperative complications related to lung cancer surgery may restrict its market growth during the evaluation period.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lung cancer surgery. The growth and trends of lung cancer surgery industry provide a holistic approach to this study.
This section of the lung cancer surgery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Surgical Devices
- Endosurgical Equipment
- Monitoring Or Visualizing Equipment
By End Users
- Robotic Surgery
- Video Assisted Surgery
- Percutaneous Surgery
- Endobronchial Surgery
- Specialty Cancer Care Centers
- Ambulatory Surgical Centers
This section covers the regional outlook, which accentuates current and future demand for the Lung Cancer Surgery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Lung Cancer Surgery Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lung cancer surgery market include Accuray Inc., Covidien, BSD Medical Corp., Richard Wolf GMBH, Angiodynamics, Siemens Healthcare, Neomend Inc., Olympus Corp., Ethicon Endo surgery Inc., Trokamed GMBH and Scanlan International Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.